These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60. Breitman TR; He RY Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989 [TBL] [Abstract][Full Text] [Related]
3. Proanthocyanidins from barley bran potentiate retinoic acid-induced granulocytic and sodium butyrate-induced monocytic differentiation of HL60 cells. Tamagawa K; Fukushima S; Kobori M; Shinmoto H; Tsushida T Biosci Biotechnol Biochem; 1998 Aug; 62(8):1483-7. PubMed ID: 9757552 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells. Takahashi T; Kobori M; Shinmoto H; Tsushida T Biosci Biotechnol Biochem; 1998 Nov; 62(11):2199-204. PubMed ID: 9972240 [TBL] [Abstract][Full Text] [Related]
5. Retinoic acid-induced monocytic differentiation of HL60/MRI, a cell line derived from a transplantable HL60 tumor. Imaizumi M; Uozumi J; Breitman TR Cancer Res; 1987 Mar; 47(5):1434-40. PubMed ID: 3469018 [TBL] [Abstract][Full Text] [Related]
6. Changes in c-myc, c-fms, and N-ras proto-oncogene expression associated with retinoic acid-induced monocytic differentiation of human leukemia HL60/MRI cells. Imaizumi M; Breitman TR Cancer Res; 1988 Dec; 48(23):6733-8. PubMed ID: 3180083 [TBL] [Abstract][Full Text] [Related]
7. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349 [TBL] [Abstract][Full Text] [Related]
8. RB phosphorylation in sodium butyrate-resistant HL-60 cells: cross-resistance to retinoic acid but not vitamin D3. Yen A; Varvayanis S J Cell Physiol; 1995 Jun; 163(3):502-9. PubMed ID: 7775593 [TBL] [Abstract][Full Text] [Related]
9. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Miranda MB; McGuire TF; Johnson DE Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350 [TBL] [Abstract][Full Text] [Related]
10. Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. Bunce CM; Wallington LA; Harrison P; Williams GR; Brown G Leukemia; 1995 Mar; 9(3):410-8. PubMed ID: 7885039 [TBL] [Abstract][Full Text] [Related]
11. Synergy between transforming growth factor-beta and tumor necrosis factor-alpha in the induction of monocytic differentiation of human leukemic cell lines. De Benedetti F; Falk LA; Ellingsworth LR; Ruscetti FW; Faltynek CR Blood; 1990 Feb; 75(3):626-32. PubMed ID: 2153423 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells. Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820 [TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid and 1 alpha,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes. Brown G; Bunce CM; Rowlands DC; Williams GR Leukemia; 1994 May; 8(5):806-15. PubMed ID: 8182938 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of cyclic AMP enhancement of retinoic acid induction of increased transglutaminase activity in HL60 cells. Maddox AM; Haddox MK Exp Cell Biol; 1988; 56(1-2):49-59. PubMed ID: 2903078 [TBL] [Abstract][Full Text] [Related]
16. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis. Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791 [TBL] [Abstract][Full Text] [Related]
17. Effect of all-trans retinoic acid and sodium butyrate in vitro and in vivo on thyroid carcinoma xenografts. Massart C; Denais A; Gibassier J Anticancer Drugs; 2006 Jun; 17(5):559-63. PubMed ID: 16702813 [TBL] [Abstract][Full Text] [Related]
18. Particular combinations of signals, by retinoic acid and 1 alpha, 25 dihydroxyvitamin D3, promote apoptosis of HL60 cells. Wallington LA; Bunce CM; Durham J; Brown G Leukemia; 1995 Jul; 9(7):1185-90. PubMed ID: 7630194 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells. Ferrari S; Donelli A; Manfredini R; Sarti M; Roncaglia R; Tagliafico E; Rossi E; Torelli G; Torelli U Cell Growth Differ; 1990 Nov; 1(11):543-8. PubMed ID: 2088479 [TBL] [Abstract][Full Text] [Related]
20. Indomethacin potentiates the induction of HL60 differentiation to neutrophils, by retinoic acid and granulocyte colony-stimulating factor, and to monocytes, by vitamin D3. Bunce CM; French PJ; Durham J; Stockley RA; Michell RH; Brown G Leukemia; 1994 Apr; 8(4):595-604. PubMed ID: 7512172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]